Trials / Not Yet Recruiting
Not Yet RecruitingNCT05824065
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
Phase III, National, Multicenter, Randomized, Double-Blind, Superiority Clinical Trial to Evaluate the Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 504 (estimated)
- Sponsor
- EMS · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OMA102 | 1 mg |
| DRUG | OMA102 | 2 mg |
| DRUG | Placebo | OMA102 - Placebo |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2023-04-21
- Last updated
- 2024-02-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05824065. Inclusion in this directory is not an endorsement.